Sava Infond’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$274K Buy
1,240
+640
+107% +$177K 0.02% 172
2026
Q1
$177K Hold
600
0.03% 189
2025
Q4
$164K Hold
600
0.02% 181
2025
Q3
$162K Hold
600
0.02% 182
2025
Q2
$165K Hold
600
0.03% 180
2025
Q1
$159K Hold
600
0.03% 177
2024
Q4
$139K Buy
+600
New +$138K 0.02% 187

Other funds holding CME

Sava Infond's CME Position: Q2 2026 in Review

Sava Infond increased its CME Group (CME) stake by 107% in Q2 2026, buying an estimated $177K and bringing the position to 1,240 shares worth $274K. The position accounts for 0.02% of the portfolio, ranked #172.

Sava Infond first reported a position in CME in Q4 2024 and has held it in 7 quarters since. 315 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Sava Infond held 1,240 shares of CME Group worth $274K as of Q2 2026.
  • Sava Infond bought 640 CME Group shares in Q2 2026, an estimated $177K.
  • CME Group made up 0.02% of Sava Infond's portfolio in Q2 2026, its #172 holding.
  • Sava Infond first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • 315 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.